Taking care of your liver
Merck Grants License to LabCorp for Development of Test To Potentially Identify Patients Likely to Respond to …
WHITEHOUSE STATION, N.J.—-Merck today announced a non-exclusive license agreement with Laboratory Corporation of America® Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy.
Read more on
Masseurs at their netas’ aching feet
Masseurs from Bangalore are moving along with Congress leaders and workers to give them a healing touch.
Read more on
Taking care of your liver
The liver is one of the body’s most important organs and needs to be protected at all times.
Read more on
